... on the epidemiology of neuroendocrine neoplasia (NEN) from around the world, including the relative frequency according to organ of origin, annual incidence rates (IR) and trends in IR at the various anatomic sites, age and stage at presentation, racial and gender differences in IR and 5-year survival rates. Over...

... Abstract Neuroendocrine neoplasms (NENs) comprise a heterogeneous group of tumors derived from multipotent neuroendocrine cells that have the inherent ability to synthesize and secrete a variety of substances (peptides and amines). When these substances are bioactive, NENs can present...

... Abstract Despite advances in radiological and metabolic imaging, standard axial endoscopy and endoscopic ultrasonography (EUS) still play a pivotal role in a number of neuroendocrine neoplasms (NENs) of the gastrointestinal and duodenopancreatic region. Upper gastrointestinal endoscopy...

... Abstract The classification of neuroendocrine neoplasms (NENs) has been evolving steadily over the last decades. Important prognostic factors of NENs are their proliferative activity and presence/absence of necrosis. These factors are reported in NENs of all body sites; however, the terminology...

... Abstract Whenever feasible, surgery represents the treatment of choice for pulmonary neuroendocrine neoplasms (NENs). In patients with hypersecreting tumors, wide metastatic spread or those not candidates for a surgical treatment, medical therapies may assure a control of the secretory pattern...

... Abstract Surgery is the only treatment that may cure the patient with gastroenteropancreatic (GEP) neuroendocrine neoplasms (NENs) and should always be considered as the first-line treatment if radical resection can be achieved. Even in cases where radical surgery is not possible, palliative...

... and glucocorticoid exposure on height deficits in children during treatment of leukemia. J Clin Endocrinol Metab 2019;104:213–222. 25. Sfeir JG, Kittah NEN, Tamhane SU, Jasim S, Chemaitilly W, Cohen LE, et al: Diagnosis of GH deficiency as a late effect of radiotherapy in survivors of childhood cancers. J Clin...

... factor 1 in irradiation-dependent growth hormone deficiency in childhood cancer survivors . Horm Res Paediatr . 2018 ; 90 : 314 – 25 . 21. Tamhane S , Sfeir JG , Kittah NEN , Jasim S , Chemaitilly W , Cohen LE , . GH therapy in childhood cancer survivors...

.... Sfeir JG , Kittah NEN , Tamhane SU , Jasim S , Chemaitilly W , Cohen LE , . Diagnosis of GH deficiency as a late effect of radiotherapy in survivors of childhood cancers . J Clin Endocrinol Metab . 2018 ; 103 ( 8 ): 2785 – 93 . 22. Corneli G , Di Somma C...

.... Cancer 2018;124:4248–4259. 24. Ma J, Siminoski K, Alos N, Halton J, Ho J, Cummings EA, et al: Impact of vertebral fractures and glucocorticoid exposure on height deficits in children during treatment of leukemia. J Clin Endocrinol Metab 2019;104:213–222. 25. Sfeir JG, Kittah NEN, Tamhane SU...

... , Sfeir JG , Kittah NEN , Jasim S , Chemaitilly W , Cohen LE , . GH therapy in childhood cancer survivors: a systematic review and meta-analysis . J Clin Endocrinol Metab . 2018 ; 103 ( 8 ): 2794 – 801 . 22. Alotaibi NM , Noormohamed N , Cote DJ...

... metastasectomy of indolent advanced neuroendocrine neoplasms (NENs) supports an aggressive surgical approach. Surgery 2011;149:209-220. 39. Scigliano S, Lebtahi R, Maire F, Stievenart JL, Kianmanesh R, Sauvanet A, et al: Clinical and imaging follow-up after exhaustive liver resection of endocrine metastases...